Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer L Taylor

Showing results (51-60 of 229) with videos related to

Pageof 23
Sort By:
Chest|November 16, 2020
Restarting Respiratory Clinical Research in the Era of the Coronavirus Disease 2019 PandemicJennifer L Taylor-Cousar, Lisa Maier, Gregory P Downey, et al.
Clinics in Chest Medicine|November 7, 2022
Update on Clinical Outcomes of Highly Effective Modulator TherapyAlex H Gifford, Jennifer L Taylor-Cousar, Jane C Davies, et al.
The Journal of Clinical Investigation|October 20, 2007
Elevated furin levels in human cystic fibrosis cells result in hypersusceptibility to exotoxin A-induced cytotoxicityWojciech Ornatowski, Jens F Poschet, Elizabeth Perkett, et al.
Frontiers in Immunology|May 31, 2021
STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure DevelopmentJessica N Filderman, Mark Appleman, Manoj Chelvanambi, et al.
Expert Review of Respiratory Medicine|February 21, 2023
Managing cystic fibrosis in children aged 6-11yrs: a critical review of elexacaftor/tezacaftor/ivacaftor combination therapyKamyron D Jordan, Edith T Zemanick, Jennifer L Taylor-Cousar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 5, 2012
Combined Tbet and IL12 gene therapy elicits and recruits superior antitumor immunity in vivoYanyan Qu, Lu Chen, Devin B Lowe, et al.
Prenatal Diagnosis|February 18, 2026
Translating Emerging Data for Fetal Treatment of Cystic FibrosisMichael V Zaretsky, Yair J Blumenfeld, Sylvia S Szentpetery, et al.
Neuropharmacology|January 26, 2006
Serotonin 2A receptor antagonist treatment reduces dopamine D1 receptor-mediated rotational behavior but not L-DOPA-induced abnormal involuntary movements in the unilateral dopamine-depleted ratJennifer L Taylor, Christopher Bishop, Thomas Ullrich, et al.
BMC Biotechnology|February 20, 2010
Characterization of a molecular switch system that regulates gene expression in mammalian cells through a small moleculeJennifer L Taylor, Priyanka Rohatgi, H Trent Spencer, et al.
Journal of Inflammation Research|November 19, 2011
Potential of anti-inflammatory treatment for cystic fibrosis lung diseaseJennifer L Taylor-Cousar, Kelsey A Von Kessel, Robert Young, et al.
Pageof 23

Showing results (51-60 of 229) with videos related to

Sort By:
Pageof 23
Chest|November 16, 2020
Restarting Respiratory Clinical Research in the Era of the Coronavirus Disease 2019 PandemicJennifer L Taylor-Cousar, Lisa Maier, Gregory P Downey, et al.
Clinics in Chest Medicine|November 7, 2022
Update on Clinical Outcomes of Highly Effective Modulator TherapyAlex H Gifford, Jennifer L Taylor-Cousar, Jane C Davies, et al.
The Journal of Clinical Investigation|October 20, 2007
Elevated furin levels in human cystic fibrosis cells result in hypersusceptibility to exotoxin A-induced cytotoxicityWojciech Ornatowski, Jens F Poschet, Elizabeth Perkett, et al.
Frontiers in Immunology|May 31, 2021
STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure DevelopmentJessica N Filderman, Mark Appleman, Manoj Chelvanambi, et al.
Expert Review of Respiratory Medicine|February 21, 2023
Managing cystic fibrosis in children aged 6-11yrs: a critical review of elexacaftor/tezacaftor/ivacaftor combination therapyKamyron D Jordan, Edith T Zemanick, Jennifer L Taylor-Cousar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 5, 2012
Combined Tbet and IL12 gene therapy elicits and recruits superior antitumor immunity in vivoYanyan Qu, Lu Chen, Devin B Lowe, et al.
Prenatal Diagnosis|February 18, 2026
Translating Emerging Data for Fetal Treatment of Cystic FibrosisMichael V Zaretsky, Yair J Blumenfeld, Sylvia S Szentpetery, et al.
Neuropharmacology|January 26, 2006
Serotonin 2A receptor antagonist treatment reduces dopamine D1 receptor-mediated rotational behavior but not L-DOPA-induced abnormal involuntary movements in the unilateral dopamine-depleted ratJennifer L Taylor, Christopher Bishop, Thomas Ullrich, et al.
BMC Biotechnology|February 20, 2010
Characterization of a molecular switch system that regulates gene expression in mammalian cells through a small moleculeJennifer L Taylor, Priyanka Rohatgi, H Trent Spencer, et al.
Journal of Inflammation Research|November 19, 2011
Potential of anti-inflammatory treatment for cystic fibrosis lung diseaseJennifer L Taylor-Cousar, Kelsey A Von Kessel, Robert Young, et al.
Pageof 23